• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand - Product Image

Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand

  • Published: November 2012
  • Region: Global
  • 221 Pages
  • GBI Research

GBI Research's report, “Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand” provides detailed insight into the global APIs market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the global APIs market.

The report contains market forecasts, product type analysis, and drivers and restraints for growth. In addition, it includes therapeutic category analysis and contract manufacturing organizations' (CMO) growth in the region, and their influence on API manufacturing activity towards 2017. Overall, the report presents a comprehensive analysis of the global APIs market, covering all the major parameters.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

The global APIs market was dominated by North America, which generated 35.1% of global API revenues in 2011. The Asia-Pacific region also saw high growth, second behind North America with a revenue share of 29.7% READ MORE >

1.1 List of Tables
1.2 List of Figures

2 Introduction

3 Global Active Pharmaceutical Ingredients Market
3.1 Global API Market Overview
3.2 Global API Market Drivers
3.2.1 Patent Expiries to Change the Dynamics of the Global API Market
3.2.2 Increased Uptake of Biologics Across Different Therapeutic Areas and Government Initiatives for Biomedical Research Set to Boost API Revenues
3.2.3 Increased Mergers and Acquisitions to Drive Global Pharmaceutical Industry Growth
3.2.4 Increasing Geographical Penetration and Elderly Population to Drive Growth of the Global Pharmaceutical and API Markets
3.2.5 Patent Expiries of Major Drugs to Support Pharmaceutical Market Revenue Growth in Underpenetrated Markets
3.3 Global API Market Restraints
3.3.1 Economic Recession to Restrict Investment in the Pharmaceutical Industry
3.3.2 Limited Improvement in Pharmaceutical Manufacturing Capabilities May Reduce Overall Growth Potential
3.3.3 Increasing Patent Expiries to Impede Growth of the Global API Market
3.3.4 Regulatory Changes to Delay the Launch of New Drugs
3.4 Global API Market Revenue Analysis and Forecast to 2017
3.4.1 Global API Market Revenue Share by Product Type
3.4.2 Global Synthetic Market Revenue Analysis and Forecast to 2017
3.4.3 Global Synthetic Market Revenue Share Analysis by Customer Base
3.4.4 Global Synthetic Market Revenue Analysis and Forecast to 2017
3.5 Global Biotech Market Analysis
3.5.1 Global Biotech Market Revenue Analysis and Forecast to 2017
3.6 Global Biotech Market Revenue Analysis by Customer Base
3.6.1 Global Biotech Market Revenue Share Analysis by Customer Base
3.6.2 Global Biotech Market Revenue Analysis and Forecast to 2017
3.7 Global Contract Manufacturing Organizations
3.7.1 Global CMO Outsourcing Process
3.7.2 Global CMO Market Drivers
3.7.3 Global CMO Market Outsourcing Benefits
3.7.4 Global CMO Market Revenues and Forecast to 2017

4 North America Active Pharmaceutical Ingredients Market
4.1 North America API Market Overview
4.2 North America API Market Drivers
4.2.1 Continuous Growth in the Pharmaceutical Industry to Sustain API Market Growth in North America
4.2.2 Generic Sector Supports the Growth of the North American API Market
4.2.3 Increasing Focus on Biological Drugs to Support API Market Revenue Growth
4.3 North American API Market Restraints
4.3.1 Recent Economic Slowdown has Restricted Pharmaceutical Industry Growth
4.3.2 High Cost of New Drug Development Hampers Innovation
4.3.3 Patent Expiries of Blockbuster Molecules to Contain API Market Growth in North America
4.4 North America API Market Revenue Analysis and Forecast to 2017
4.5 North America API Market Revenue Share Analysis by Product Type
4.6 North America Synthetic Market Analysis
4.6.1 North America Synthetic Market Revenue Analysis and Forecast to 2017
4.6.2 North America Synthetic Market Revenue Share Analysis by Customer Base
4.6.3 North America Synthetic Market Revenue Analysis by Customer Base and Forecast to 2017
4.7 North America Biotech Market Analysis
4.7.1 North America Biotech Market Revenue Analysis and Forecast to 2017
4.7.2 North America Biotech Market Revenue Share Analysis by Customer Base
4.7.3 North America Biotech Market Revenue Analysis by Customer Base and Forecast to 2017
4.8 North America API Market Revenue Share Analysis by Therapeutic Applications
4.9 The US Active Pharmaceutical Ingredients Market
4.9.1 The US API Market Overview
4.9.2 The US API Market Revenue by Product Type and Forecast to 2017
4.9.3 The US API Market Revenue Share Analysis by Product Type and Forecast to 2017
4.9.4 The US API Market by Customer Base
4.10 Canada Active Pharmaceutical Ingredients Market
4.10.1 Canada API Market Overview
4.10.2 Canada API Market Revenue Analysis by Product Type and Forecast to 2017
4.10.3 Canada API Market Revenue Share Analysis by Product Types and Forecast to 2017
4.10.4 Canada API Market by Customer Base

5 Asia-Pacific Active Pharmaceutical Ingredients Market
5.1 Asia-Pacific API Market Overview
5.2 Asia-Pacific APIs Market Drivers
5.2.1 Pharmaceutical Manufacturing Capabilities in Developing Countries such as China and India to Attract API Manufacture
5.2.2 Domestic Market Growth of Developing Countries in Asia-Pacific to Drive Global Pharmaceutical Industry Growth
5.2.3 Increasing Focus on Biotech API Drugs in Asia-Pacific will Contribute to Major Asia-Pacific API Market Growth
5.2.4 Improving Regulatory Framework in China and India is Increasing Penetration for Branded Drugs
5.2.5 Patent Expiries of Blockbuster Drugs to Boost Market Revenues in Asia-Pacific Markets
5.3 Asia-Pacific API Market Restraints
5.3.1 Increasing Incidence of Patent Expiries to Hamper Growth for Branded API Market
5.3.2 Highly Fragmented Market to Restrict Revenue Growth for the Asia-Pacific API Market
5.3.3 Limited Improvement in Pharmaceutical Manufacturing Capabilities may Hamper Overall Growth Potential
5.3.4 Currency Fluctuations to Hamper Value Growth of Pharmaceutical Market in Asia-Pacific Region
5.4 Asia-Pacific API Market Revenue and Forecasts to 2017
5.5 Asia-Pacific Revenue Share Analysis by Product Type
5.6 Asia-Pacific Synthetic Market
5.6.1 Asia-Pacific Synthetic Market Revenues and Forecast to 2017
5.6.2 Asia-Pacific Synthetic Market Revenue Share Analysis by Consumer Base
5.6.3 Asia-Pacific Synthetic Market Revenues by Customer Base and Forecast to 2017
5.7 Asia-Pacific Biotech Market
5.7.1 Asia-Pacific Biotech Market Revenues and Forecasts to 2017
5.7.2 Asia-Pacific Biotech Market Revenue Share Analysis by Customer Base
5.7.3 Asia-Pacific Biotech Market Revenue by Customer Base and Forecast to 2017
5.8 Asia-Pacific API Market Share Analysis by Therapeutic Applications
5.9 Japan Active Pharmaceutical Ingredients Market
5.9.1 Japan API Market Overview
5.9.2 Japan API Market Revenues and Forecasts to 2017
5.9.3 Japan API Market Revenue Share Analysis by Product Type
5.9.4 Japan API Market by Customer Base
5.10 China Active Pharmaceutical Ingredients Market
5.10.1 China API Market Overview
5.10.2 China API Market Revenues by Product Type and Forecasts to 2017
5.10.3 China API Market Revenue Share Analysis by Product Types
5.10.4 China API Market by Customer Base
5.11 South Korea Active Pharmaceutical Ingredients Market
5.11.1 South Korea API Market Overview
5.11.2 South Korea APIs Market Revenue and Forecasts to 2017
5.11.3 South Korea API Market Revenue Share Analysis by Product Type
5.11.4 South Korea API Market by Customer Base
5.12 India Active Pharmaceutical Ingredients Market
5.12.1 India API Market Overview
5.12.2 India API Market Revenue and Forecasts to 2017
5.12.3 India API Market Revenue Share Analysis by Product Types
5.12.4 India API Market by Customer Base

6 Europe Active Pharmaceutical Ingredients Market
6.1 Europe API Market Overview
6.2 Europe API Market Drivers
6.2.1 Increased CMO Opportunities Expected to Improve the Production of Generics and Drive API Revenue Growth in Europe
6.2.2 Overall Growth in the Pharmaceutical Industry and Increasing Elderly Population to Drive the Growth for the European API Market
6.2.3 Biopharmaceutical Therapies to Support API Market Growth in Europe
6.2.4 European Regulatory Framework to Facilitate Development of Biosimilars
6.2.5 Differences in VAT rates on Pharma Products to Increase Parallel Trade in Europe
6.3 Europe API Market Restraints
6.3.1 Increased Consumption of Generics to Limit the Premium Earned from Branded Products
6.3.2 Increasing Patent Expiries to Hamper the Growth of the European API Market
6.3.3 Price Cuts to Restrict Revenue Growth for the European API Market
6.4 Europe API Market Revenue Analysis and Forecast to 2017
6.5 Europe API Market Revenue Share Analysis by Product Type
6.6 Europe Synthetic Market Analysis
6.6.1 Europe Synthetic Market Revenue Analysis and Forecast to 2017
6.6.2 European Synthetic Market Revenue Share Analysis by Customer Base
6.6.3 Europe Synthetic Market Revenue by Customer Base and Forecast to 2017
6.7 Europe Biotech Market Analysis
6.7.1 Europe Biotech Market Revenue Analysis and Forecast to 2017
6.7.2 Europe Biotech Market Revenue Share Analysis by Customer Base
6.7.3 Europe Biotech Market Revenues by Customer Base and Forecast to 2017
6.8 Europe API Market Revenue Share Analysis by Therapeutic Applications
6.9 Germany Active Pharmaceutical Ingredients Market
6.9.1 Germany API Market Overview
6.9.2 Germany API Market Revenue Analysis by Product Type and Forecast to 2017
6.9.3 Germany API Market Revenue Share Analysis by Product Type and Forecast to 2017
6.9.4 Germany API Market by Customer Base
6.10 France Active Pharmaceutical Ingredients Market
6.10.1 France API Market Overview
6.10.2 France API Market Revenue Analysis by Product Type and Forecast to 2017
6.10.3 France API Revenue Share Analysis by Product Type and Forecast to 2017
6.10.4 France API Market by Customer Base
6.11 Italy Active Pharmaceutical Ingredients Market
6.11.1 Italy API Market Overview
6.11.2 Italy API Market Revenue Analysis by Product Type and Forecast to 2017
6.11.3 Italy API Market Revenue Share Analysis by Product Type and Forecast to 2017
6.11.4 Italy API Market by Customer Base
6.12 The UK Active Pharmaceutical Ingredients Market
6.12.1 The UK API Market Overview
6.12.2 The UK API Market Revenue Analysis by Product Type and Forecast to 2017
6.12.3 The UK API Market Revenue Share Analysis by Product Types and Forecast to 2017
6.12.4 The UK API Market by Customer Base
6.13 Spain Active Pharmaceutical Ingredients Market
6.13.1 Spain API Market Overview
6.13.2 Spain API Market Revenue Analysis by Product Type and Forecast to 2017
6.13.3 Spain API Market Revenue Share Analysis by Product Types and Forecast to 2017
6.13.4 Spain API Market by Customer Base

7 Appendix
7.1 Abbreviations
7.2 Bibliography
7.3 Market Definitions
7.4 Methodology
7.4.1 Coverage
7.4.2 Secondary Research
7.4.3 Primary Research
7.4.4 Expert Panel Validation
7.5 Contact Us
7.6 Disclaimer

1.1 List of Tables
Table 1: API Market, Global, Total Revenue Analysis, $m, 2005–2017
Table 2: API Market, Global, Revenue Share by Product Types, %, 2011
Table 3: Synthetic Market, Global, Revenue Analysis, $m, 2005–2017
Table 4: Synthetic Market, Global, Revenue Share Analysis by Region, %, 2011
Table 5: Synthetic Market, Global, Revenue Share Analysis by Region, %, 2005–2017
Table 6: Synthetic Market, Global, Revenue Share by Customer Base, %, 2011
Table 7: Synthetic Market, Global, Revenue Analysis by Customer Base, $m, 2005–2017
Table 8: Biotech Market, Global, Revenue Analysis, $m, 2005–2017
Table 9: Biotech Market, Global, Revenue Share by Region, %, 2011
Table 10: Biotech Market, Global, Revenue Share Analysis by Region, %, 2005–2017
Table 11: Biotech Market, Global, Revenue Share Analysis by Customer Base, %, 2011
Table 12: Biotech Market, Global, Revenue Analysis by Customer Base, $m, 2005–2017
Table 13: CMO Market, Asia-Pacific, Fine Chemical Industry Labor Cost, $/Operator/Year, 2011
Table 14: CMO Market, Global, Market Revenues, $m, 2005–2017
Table 15: API Market, North America, Major Drugs to Lose Patent Protection, 2012–2016
Table 16: API Market, North America, Revenue Analysis by Product Type, $m, 2005–2017
Table 17: API Market, North America, Revenue Share by Product Type, %, 2005–2017
Table 18: Synthetic Market, North America, Revenue Analysis, $m, 2005–2017
Table 19: Synthetic Market, North America, Revenue Share Analysis by Countries, $m and %, 2011
Table 20: Synthetic Market, North America, Revenue Share Trend, %, 2005–2017
Table 21: Synthetic Market, North America, Revenue Share by Customer Base, (%), 2011
Table 22: Synthetic Market, North America, Revenue Analysis by Customer Base, $m, 2005–2017
Table 23: Biotech Market, North America, Revenue Analysis, $m, 2005–2017
Table 24: Biotech Market, North America, Revenue Share by Countries, $m and %, 2011
Table 25: Biotech Market, North America, Revenue Share Trend, %, 2005–2017
Table 26: Biotech Market, North America, Revenue Share Analysis by Customer Base, %, 2011
Table 27: Biotech Market, North America, Revenue Analysis by Customer Base, $m, 2005–2017
Table 28: API Market, North America, Revenue Split by Therapeutic Applications, %, 2011–2017
Table 29: API Market, The US, Revenue Analysis by Product Type, $m, 2005–2017
Table 30: API Market, The US, Revenue Share Analysis by Product Type, %, 2005–2017
Table 31: Synthetic Market, The US, Revenue Analysis by Customer Base, $m, 2005–2017
Table 32: Synthetic Market, The US, Revenue Share by Customer Base, %, 2005–2017
Table 33: Biotech Market, The US, Revenue Analysis by Customer Base, $m, 2005–2017
Table 34: Biotech Market, The US, Revenue Share by Customer Base, %, 2005–2017
Table 35: API Market, Canada, Revenue Analysis by Product Type, $m, 2005–2017
Table 36: API Market, Canada, Revenue Share by Product Type, %, 2005–2017
Table 37: Synthetic Market, Canada, Revenue Analysis by Customer Base, $m, 2005–2017
Table 38: Synthetic Market, Canada, Revenue Share by Customer Base, %, 2005–2017
Table 39: Biotech Market, Canada, Revenue Analysis by Customer Base, $m, 2005–2017
Table 40: Biotech Market, Canada, Revenue Share by Customer Base, %, 2005–2017
Table 41: API Market, Asia-Pacific, Market Revenues, $m, 2005–2017
Table 42: API Market, Asia-Pacific, Revenue Share by Product Types, $m and %, 2011
Table 43: Synthetic Market, Asia-Pacific, Market Revenues, $m, 2005–2017
Table 44: Synthetic Market, Asia-Pacific, Revenue Share Analysis by Countries, $m and %, 2011
Table 45: Synthetic Market, Asia-Pacific, Revenue Analysis by Countries, $m, 2005–2017
Table 46: Synthetic Market, Asia-Pacific, Revenue Share by Customer Base, %, 2011
Table 47: Synthetic Market, Asia-Pacific, Market Revenues by Product Types, $m, 2005–2017
Table 48: Biotech Market, Asia-Pacific, Market Revenues, $m, 2005–2017
Table 49: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries, $m and %, 2011
Table 50: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries, $m, 2005, 2011 and 2017
Table 51: Biotech Market, Asia-Pacific, Revenue Share Analysis by Customer Base, $m and %, 2011
Table 52: Biotech Market, Asia-Pacific, Market Revenues by Product Type, $m, 2005–2017
Table 53: API Market, Asia-Pacific, Revenue Share Analysis by Therapeutic Applications, %, 2011–2017
Table 54: API Market, Japan, Market Revenues by Product Types, $m, 2005–2017
Table 55: API Market, Japan, Revenue Share Analysis by Product Types, %, 2005–2017
Table 56: Synthetic Market, Japan, Market Revenues by Customer Base, $m, 2005–2017
Table 57: Synthetic Market, Japan, Revenue Share by Customer Base, %, 2005–2017
Table 58: Biotech Market, Japan, Market Revenues by Customer Base, $m, 2005–2017
Table 59: Biotech Market, Japan, Revenue Share Analysis by Customer Base, %, 2005–2017
Table 60: API Market, China, Market Revenues by Product Type, $m, 2005–2017
Table 61: API Market, China, Revenue Share Analysis by Product Type, %, 2005–2017
Table 62: Synthetic Market, China, Market Revenues by Customer Base, $m, 2005–2017
Table 63: Synthetic Market, China, Revenue Share Analysis by Customer Base, %, 2005–2017
Table 64: Biotech Market, China, Market Revenues by Customer Base, $m, 2005–2017
Table 65: Biotech Market, China, Revenue Share Analysis by Customer Base, %, 2005–2017
Table 66: API Market, South Korea, Market Revenues by Product Types, $m, 2005–2017
Table 67: API Market, South Korea, Revenue Share Analysis by Product Types, %, 2005–2017
Table 68: Synthetic Market, South Korea, Market Revenues by Customer Base, $m, 2005–2017
Table 69: Synthetic Market, South Korea, Revenue Share Analysis by Customer Base, %, 2005–2017
Table 70: Biotech Market, South Korea, Market Revenues by Customer Base, $m, 2005–2017
Table 71: Biotech Market, South Korea, Revenue Share Analysis by Customer Base, %, 2005–2017
Table 72: API Market, India, Market Revenues by Product Types, $m, 2005–2017
Table 73: API Market, India, Revenue Share Analysis by Product Types, %, 2005–2017
Table 74: Synthetic Market, India, Market Revenues by Customer Base, $m, 2005–2017
Table 75: Synthetic Market, India, Revenue Share Analysis by Customer Base, %, 2005–2017
Table 76: Biotech Market, India, Market Revenues by Customer Base, $m, 2005–2017
Table 77: Biotech Market, India, Revenue Share Analysis by Customer Base, %, 2005–2017
Table 78: Pharmaceutical Market, Leading Five European Countries, Pricing and Reimbursement Mechanism, 2011
Table 79: API Market, Europe, Total Revenue Analysis, $m, 2005–2017
Table 80: API Market, Europe, Revenue Share by Product Types, %, 2011
Table 81: Synthetic Market, Europe, Revenue Analysis, $m, 2005–2017
Table 82: Synthetic Market, Europe, Revenue Share Analysis by Countries, %, 2011
Table 83: Synthetic Market, Europe, Revenue Share Trend, %, 2005–2017
Table 84: Synthetic Market, Europe, Revenue Share by Customer Base, %, 2011
Table 85: Synthetic Market, Europe, Revenue Analysis by Customer Base, $m, 2005–2017
Table 86: Biotech Market, Europe, Revenue Analysis, $m, 2005–2017
Table 87: Biotech Market, Europe, Revenue Share by Countries, %, 2011
Table 88: Biotech Market, Europe, Revenue Share Trend, %, 2005–2017
Table 89: Biotech Market, Europe, Revenue Share Analysis by Customer Base, %, 2011
Table 90: Biotech Market, Europe, Revenue Analysis by Customer Base, $m, 2005–2017
Table 91: API Market, Europe, Revenue Split by Therapeutic Applications, %, 2011–2017
Table 92: API Market, Germany, Revenue Analysis by Product Types, $m, 2005–2017
Table 93: API Market, Germany, Revenue Share by Product Type, %, 2005–2017
Table 94: Synthetic Market, Germany, Revenue Analysis by Customer Base, $m, 2005–2017
Table 95: Synthetic Market, Germany, Revenue Share by Customer Base, %, 2005–2017
Table 96: Biotech Market, Germany, Revenue Analysis by Customer Base, $m, 2005–2017
Table 97: Biotech Market, Germany, Revenue Share by Customer Base, %, 2005–2017
Table 98: API Market, France, Revenue Analysis by Product Types, $m, 2005–2017
Table 99: API Market, France, Revenue Share by Product Type, %, 2005–2017
Table 100:Synthetic Market, France, Revenue Analysis by Customer Base, $m, 2005–2017
Table 101:Synthetic Market, France, Revenue Share by Customer Base, %, 2005–2017
Table 102:Biotech Market, France, Revenue Analysis by Customer Base, $m, 2005–2017
Table 103:Biotech Market, France, Revenue Share by Customer Base, %, 2005–2017
Table 104:API Market, Italy, Revenue Analysis by Product Types, $m, 2005–2017
Table 105:API Market, Italy, Revenue Share by Product Type, %, 2005–2017
Table 106:Synthetic Market, Italy, Revenue Analysis by Customer Base, $m, 2005–2017
Table 107:Synthetic Market, Italy, Revenue Share by Customer Base, %, 2005–2017
Table 108:Biotech Market, Italy, Revenue Analysis by Customer Base, $m, 2005–2017
Table 109:Biotech Market, Italy, Revenue Share by Customer Base, %, 2005–2017
Table 110:API Market, The UK, Revenue Analysis by Product Types, $m, 2005–2017
Table 111:API Market, The UK, Revenue Share by Product Type, %, 2005–2017
Table 112:Synthetic Market, The UK, Revenue Analysis by Customer Base, $m, 2005–2017
Table 113:Synthetic Market, The UK, Revenue Share by Customer Base, %, 2005–2017
Table 114:Biotech Market, The UK, Revenue Analysis by Customer Base, $m, 2005–2017
Table 115:Biotech Market, The UK, Revenue Share by Customer Base, %, 2005–2017
Table 116:API Market, Spain, Revenue Analysis by Product Types, $m, 2005–2017
Table 117:API Market, Spain, Revenue Share by Product Type, %, 2005–2017
Table 118:Synthetic Market, Spain, Revenue Analysis by Customer Base, $m, 2005–2017
Table 119:Synthetic Market, Spain, Revenue Share by Customer Base, %, 2005–2017
Table 120:Biotech Market, Spain, Revenue Analysis by Customer Base, $m, 2005–2017
Table 121:Biotech Market, Spain, Revenue Share by Customer Base, %, 2005–2017

1.2 List of Figures
Figure 1: API Market, Global, Total Revenue Analysis ($m), 2005–2017
Figure 2: API Market, Global, Revenue Share by Product Type (%), 2011
Figure 3: Synthetic Market, Global, Revenue Analysis ($m), 2005–2017
Figure 4: Synthetic Market, Global, Revenue Share Analysis (%), 2011
Figure 5: Synthetic Market, Global, Revenue Share Analysis by Region (%), 2005–2017
Figure 6: Synthetic Market, Global, Revenue Share by Customer Base (%), 2011
Figure 7: Synthetic Market, Global, Revenue Analysis by Customer Base ($m), 2005–2017
Figure 8: Biotech Market, Global, Revenue Analysis ($m), 2005–2017
Figure 9: Biotech Market, Global, Revenue Share by Region (%), 2011
Figure 10: Biotech Market, Global, Revenue Share Analysis by Region (%), 2005–2017
Figure 11: Biotech Market, Global, Revenue Share Analysis by Customer Base (%), 2011
Figure 12: Biotech Market, Global, Revenue Analysis by Customer Base ($m), 2005–2017
Figure 13: CMO Market, Global, Process for Selection of CMO and Management of Outsourcing Project
Figure 14: CMO Market, Asia-Pacific, Fine Chemical Industry Labor Cost ($/Operator/Year), 2011
Figure 15: CMO Market Key Benefits of Outsourcing to CMOs
Figure 16: CMO Market, Global, Market Revenue ($m), 2005-2017
Figure 17: API Market, North America, Revenue Analysis by Product Type ($m), 2005–2017
Figure 18: API Market, North America, Revenue Share by Product Type (%), 2005–2017
Figure 19: Synthetic Market, North America, Revenue Analysis ($m), 2005–2017
Figure 20: Synthetic Market, North America, Revenue Share Analysis by Countries (%), 2011
Figure 21: Synthetic Market, North America, Performance and Potential Analysis Grid (%), 2005–2017
Figure 22: Synthetic Market, North America, Revenue Share Trend Analysis by Countries (%), 2005–2017
Figure 23: Synthetic API, North America, Revenue Share by Customer Base (%), 2011
Figure 24: Synthetic Market, North America, Revenue Analysis by Customer Base ($m), 2005–2017
Figure 25: Biotech Market, North America, Revenue Analysis ($m and %), 2005–2017
Figure 26: Biotech Market, North America, Revenue Share by Countries (%), 2011
Figure 27: Biotech Market, North America, Performance and Potential Analysis Grid (%), 2005–2017
Figure 28: Biotech Market, North America, Revenue Share Trend (%), 2005–2017
Figure 29: Biotech Market, North America, Revenue Share Analysis by Customer Base (%), 2011
Figure 30: Biotech Market, North America, Revenue Analysis by Customer Base ($m), 2005–2017
Figure 31: API Market, North America, Revenue Split by Therapeutic Applications (%), 2011–2017
Figure 32: API Market, The US, Revenue Analysis by Product Type ($m), 2005–2017
Figure 33: API Market, The US, Revenue Share Analysis by Product Type (%), 2005–2017
Figure 34: Synthetic Market, The US, Revenue Analysis by Customer Base ($m), 2005–2017
Figure 35: Synthetic Market, The US, Revenue Share by Customer Base (%), 2005–2017
Figure 36: Biotech API, The US, Revenue Analysis by Customer Base ($m), 2005–2017
Figure 37: Biotech Market, The US, Revenue Share by Customer Base (%), 2005–2017
Figure 38: API Market, Canada, Revenue Analysis by Product Type ($m), 2005–2017
Figure 39: API Market, Canada, Revenue Share by Product Type (%), 2005–2017
Figure 40: Synthetic Market, Canada, Revenue Analysis by Customer Base ($m), 2005–2017
Figure 41: Synthetic Market, Canada, Revenue Share by Customer Base (%), 2005–2017
Figure 42: Biotech Market, Canada, Revenue Analysis by Customer Base ($m), 2005–2017
Figure 43: Biotech Market, Canada, Revenue Share by Customer Base (%), 2005–2017
Figure 44: API Market, Asia-Pacific, Market Revenues ($m), 2005–2017
Figure 45: API Market, Asia-Pacific, Revenue Share by Product Type (%), 2011
Figure 46: Synthetic Market, Asia-Pacific, Market Revenues ($m), 2005–2017
Figure 47: Synthetic Market, Asia-Pacific, Revenue Share Analysis by Countries (%), 2011
Figure 48: Synthetic Market, Asia-Pacific, Performance and Potential Analysis Grid (%), 2005–2017
Figure 49: Synthetic Market, Asia-Pacific, Revenue Analysis by Countries (%), 2005–2017
Figure 50: Synthetic Market, Asia-Pacific, Revenue Share by Customer Base (%), 2011
Figure 51: Synthetic Market, Asia-Pacific, Revenue Trend Analysis by Product Type ($m), 2005–2017
Figure 52: Biotech Market, Asia-Pacific, Market Revenues ($m and %), 2005–2017
Figure 53: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries (%), 2011
Figure 54: Biotech Market, Asia-Pacific, Performance and Potential Analysis Grid (%), 2005–2017
Figure 55: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries ($m), 2005–2017
Figure 56: Biotech Market, Asia-Pacific, Revenue Share Analysis by Customer Base (%), 2011
Figure 57: Biotech Market, Asia-Pacific, Market Revenues by Product Type ($m), 2005–2017
Figure 58: API Market, Asia-Pacific, Revenue Share Analysis by Therapeutic Applications (%), 2011–2017
Figure 59: API Market, Japan, Market Revenues by Product Type ($m), 2005–2017
Figure 60: API Market, Japan, Revenue Share Analysis by Product Types (%), 2005–2017
Figure 61: Synthetic Market, Japan, Market Revenues by Customer Base ($m), 2005–2017
Figure 62: Synthetic Market, Japan, Revenue Share by Customer Base (%), 2005–2017
Figure 63: Biotech Market, Japan, Market Revenues by Customer Base ($m), 2005–2017
Figure 64: Biotech Market, Japan, Revenue Share Analysis by Customer Base (%), 2005–2017
Figure 65: API Market, China, Market Revenues by Product Type ($m), 2005–2017
Figure 66: API Market, China, Revenue Share Analysis by Product Type (%), 2005–2017
Figure 67: Synthetic Market, China, Market Revenues by Customer Base ($m), 2005–2017
Figure 68: Synthetic Market, China, Revenue Share Analysis by Customer Base (%), 2005–2017
Figure 69: Biotech Market, China, Market Revenues by Customer Base ($m), 2005–2017
Figure 70: Biotech Market, China, Revenue Share Analysis by Customer Base (%), 2005–2017
Figure 71: API Market, South Korea, Market Revenues by Product Type ($m), 2005–2017
Figure 72: API Market, South Korea, Revenue Share Analysis by Product Types (%), 2005–2017
Figure 73: Synthetic Market, South Korea, Market Revenues by Customer Base ($m), 2005–2017
Figure 74: Synthetic Market, South Korea, Revenue Share Analysis by Customer Base (%), 2005–2017
Figure 75: Biotech Market, South Korea, Market Revenues by Customer Base ($m), 2005–2017
Figure 76: Biotech Market, South Korea, Revenue Share Analysis by Customer Base (%), 2005–2017
Figure 77: API Market, India, Market Revenues by Product Types ($m), 2005–2017
Figure 78: API Market, India, Revenue Share Analysis by Product Types (%), 2005–2017
Figure 79: Synthetic Market, India, Market Revenues by Customer Base ($m), 2005–2017
Figure 80: Synthetic Market, India, Revenue Share Analysis by Customer Base (%), 2005–2017
Figure 81: Biotech Market, India, Market Revenues by Customer Base ($m), 2005–2017
Figure 82: Biotech Market, India, Revenue Share Analysis by Customer Base (%), 2005–2017
Figure 83: API Market, Europe, Total Revenue Analysis ($m), 2005–2017
Figure 84: API Market, Europe, Revenue Share by Product Types (%), 2011
Figure 85: Synthetic Market, Europe, Revenue Analysis ($m), 2005–2017
Figure 86: Synthetic Market, Europe, Revenue Share Analysis by Countries (%), 2011
Figure 87: Synthetic Market, Europe, Performance and Potential Analysis Grid (%), 2005–2017
Figure 88: Synthetic Market, Europe, Revenue Share Trend Analysis by Countries (%), 2005–2017
Figure 89: Synthetic Market, Europe, Revenue Share by Customer Base, (%), 2011
Figure 90: Synthetic Market, Europe, Revenue Trend by Product Types ($m), 2005–2017
Figure 91: Biotech Market, Europe, Revenue Analysis ($m and %), 2005–2017
Figure 92: Biotech Market, Europe, Revenue Share by Countries (%), 2011
Figure 93: Biotech Market, Europe, Performance and Potential Analysis Grid (%), 2005–2017
Figure 94: Biotech Market, Europe, Revenue Share Trend (%), 2005–2017
Figure 95: Biotech Market, Europe, Revenue Share Analysis by Customer Base (%), 2011
Figure 96: Biotech Market, Europe, Revenue Analysis by Customer Base ($m), 2005–2017
Figure 97: API Market, Europe, Revenue Split by Therapeutic Applications (%), 2011–2017
Figure 98: API Market, Germany, Revenue Analysis by Product Types ($m), 2005–2017
Figure 99: API Market, Germany, Revenue Share by Product Type (%), 2005–2017
Figure 100: Synthetic Market, Germany, Revenue Analysis by Customer Base ($m), 2005–2017
Figure 101: Synthetic Market, Germany, Revenue Share by Customer Base (%), 2005–2017
Figure 102: Biotech Market, Germany, Revenue Analysis by Customer Base ($m), 2005–2017
Figure 103: Biotech Market, Germany, Revenue Share by Customer Base (%), 2005–2017
Figure 104: API Market, France, Revenue Analysis by Product Types ($m), 2005–2017
Figure 105: API Market, France, Revenue Share by Product Type (%), 2005–2017
Figure 106: Synthetic Market, France, Revenue Analysis by Customer Base ($m), 2005–2017
Figure 107: Synthetic Market, France, Revenue Share by Customer Base (%), 2005–2017
Figure 108: Biotech Market, France, Revenue Analysis by Customer Base ($m), 2005–2017
Figure 109: Biotech Market, France, Revenue Share by Customer Base (%), 2005–2017
Figure 110: API Market, Italy, Revenue Analysis by Product Types ($m), 2005–2017
Figure 111: API Market, Italy, Revenue Share by Product Type (%), 2005–2017
Figure 112: Synthetic Market, Italy, Revenue Analysis by Customer Base ($m), 2005–2017
Figure 113: Synthetic Market, Italy, Revenue Share by Customer Base (%), 2005–2017
Figure 114: Biotech Market, Italy, Revenue Analysis by Customer Base ($m), 2005–2017
Figure 115: Biotech Market, Italy, Revenue Share by Customer Base (%), 2005–2017
Figure 116: API Market, The UK, Revenue Analysis by Product Types ($m), 2005–2017
Figure 117: API Market, The UK, Revenue Share by Product Type (%), 2005–2017
Figure 118: Synthetic Market, The UK, Revenue Analysis by Customer Base ($m), 2005–2017
Figure 119: Synthetic Market, The UK, Revenue Share by Customer Base (%), 2005–2017
Figure 120: Biotech Market, The UK, Revenue Analysis by Customer Base ($m), 2005–2017
Figure 121: Biotech Market, The UK, Revenue Share by Customer Base (%), 2005–2017
Figure 122: API Market, Spain, Revenue Analysis by Product Types ($m), 2005–2017
Figure 123: API Market, Spain, Revenue Share by Product Type (%), 2005–2017
Figure 124: Synthetic Market, Spain, Revenue Analysis by Customer Base ($m), 2005–2017
Figure 125: Synthetic Market, Spain, Revenue Share by Customer Base (%), 2005–2017
Figure 126: Biotech Market, Spain, Revenue Analysis by Customer Base ($m), 2005–2017
Figure 127: Biotech Market, Spain, Revenue Share by Customer Base (%), 2005–2017

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos